Find comprehensive information on Parathyroidectomy including clinical documentation requirements, medical coding guidelines, and healthcare resources. Learn about ICD-10-CM codes, CPT codes, postoperative care, complications, and recovery for parathyroid surgery. This resource provides essential information for healthcare professionals, medical coders, and patients seeking information on parathyroid gland removal surgery. Explore details on parathyroid adenoma excision, hyperparathyroidism treatment, and surgical pathology related to parathyroidectomy.
Also known as
Operations on thyroid and parathyroid
Includes surgical procedures on the thyroid and parathyroid glands.
Endocrine, nutritional and metabolic diseases
Covers disorders of the endocrine system affecting metabolism and nutrition.
Other specified metabolic disorders
Includes other specified disorders related to metabolism not classified elsewhere.
Follow this step-by-step guide to choose the correct ICD-10 code.
Was the parathyroidectomy total?
Yes
Any complications?
No
Partial or other?
When to use each related code
| Description |
|---|
| Parathyroidectomy |
| Primary Hyperparathyroidism |
| Hypoparathyroidism |
Missing or incorrect laterality (right, left, bilateral) for parathyroidectomy may lead to inaccurate reimbursement and data reporting.
Documentation must clearly distinguish between exploration only and complete/partial removal of parathyroid gland(s) for proper code assignment.
Lack of documentation linking parathyroidectomy to a specific medical condition (e.g., hyperparathyroidism) may impact medical necessity reviews.
Q: What are the most reliable intraoperative methods for confirming successful parathyroidectomy in patients with primary hyperparathyroidism?
A: Confirming successful parathyroidectomy during surgery for primary hyperparathyroidism relies on a combination of techniques. Intraoperative parathyroid hormone (iPTH) monitoring, demonstrating a significant drop from baseline, is often considered the gold standard. A drop of 50% or more from baseline, or reaching a normal iPTH level 10 minutes after gland excision, is generally accepted. Quick intraoperative parathyroid hormone assay (QPTH) is a common method for iPTH measurement. Alongside iPTH monitoring, surgeons might utilize radioguided techniques with sestamibi or methylene blue dye, allowing for precise localization and visualization of the affected gland(s). Surgeons also consider the gross appearance of the excised tissue and frozen section analysis when rapid pathology assessment is available. Explore how combined methods enhance accuracy in parathyroidectomy confirmation and minimize the risk of persistent or recurrent hyperparathyroidism. Consider implementing standardized iPTH protocols in your practice to improve surgical outcomes.
Q: How do I differentiate between single and multi-gland disease in patients presenting with primary hyperparathyroidism prior to parathyroidectomy?
A: Differentiating between single and multi-gland disease in primary hyperparathyroidism is crucial for surgical planning. While traditionally, sestamibi scans and ultrasound were primary localization techniques, advancements like 4D-CT and single-photon emission computed tomography (SPECT) offer improved sensitivity and specificity. High-resolution imaging can detect even small or ectopic parathyroid adenomas. Elevated serum calcium and parathyroid hormone levels, along with clinical features, contribute to the overall assessment. However, genetic testing for MEN syndromes (multiple endocrine neoplasia) should be considered in cases with strong family history or suggestive clinical manifestations, as these syndromes are associated with multi-gland disease. Learn more about the latest imaging modalities and genetic testing strategies for precise pre-operative localization and personalized parathyroidectomy approaches. Consider incorporating advanced imaging protocols into your diagnostic workup to improve surgical planning and patient outcomes.
Patient presents with signs and symptoms suggestive of primary hyperparathyroidism, including elevated calcium levels, hypercalcemia, nephrolithiasis, osteoporosis, bone pain, fatigue, and muscle weakness. Laboratory findings reveal elevated parathyroid hormone (PTH) levels, confirming the diagnosis. Imaging studies, including neck ultrasound and sestamibi scan, were performed to localize the parathyroid adenoma. The patient's clinical presentation, laboratory data, and imaging results meet the diagnostic criteria for parathyroid adenoma requiring surgical intervention. Parathyroidectomy is indicated and discussed with the patient, including the risks and benefits of the procedure. Surgical approach, potential complications such as hypocalcemia and recurrent laryngeal nerve injury, and post-operative management, including calcium and vitamin D supplementation, were explained. The patient consented to the procedure. Pre-operative assessment, including electrocardiogram (ECG) and basic metabolic panel, is complete, and the patient is cleared for surgery. Medical billing codes will include appropriate ICD-10 codes for primary hyperparathyroidism and CPT codes for parathyroidectomy, reflecting the complexity of the procedure. Post-operative care will focus on monitoring calcium levels, managing potential hypocalcemia, and evaluating for any surgical complications.